HEALTH CARE INDUSTRY - PHARMA AND TECH +++ +++

HEALTH CARE INDUSTRY MedPage Today: Physician-Produced Videos On Internet Flunk Evidence Test Fewer than 20% of online health information videos produced by health professionals had high-quality evidence to support claims made in the videos, according to a review of content on the popular YouTube video platform. Two-thirds of the videos, all related to cancer or diabetes, had low, very low, or no evidence to support health claims. About 15% of the 309 videos had moderate-quality evidence. A multivariate analysis showed that videos with lower-quality evidence attracted more views than those with the highest level of evidence. (Bankhead, 1/14) https://www.medpagetoday.com/primarycare/generalprimarycare/119571?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--IQQ56wqRN7A0fJNkzX7637lDix71d87ZGH96gqidNkYfzOELpMcgYDK9mW9b850z388M7_J8RBuIpR26Pz-bHKUZ47Q&_hsmi=400350224&utm_content=400350224&utm_source=hs_email Aurora Beacon-News: VNA Health Care To Expand Indian Avenue Center In Aurora VNA Health Care is planning to expand one of its busiest health centers in Aurora with the help of a recently-announced $750,000 award from Endeavor Health. (Smith, 1/23) https://www.chicagotribune.com/2026/01/23/vna-health-care-to-expand-indian-avenue-health-center-in-aurora/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8m7722EhhtB2ViVWFi65KFQMcR8ZNDX85kW1IyYS1n31ooJeq2shgeQ_O7q0ZNqNm6km7ZAdVZTXCxfFd37-47w44lwA&_hsmi=400350224&utm_content=400350224&utm_source=hs_email The (Cleveland) Plain Dealer: Ohio Nursing Homes Still Waiting On $1 Billion Supreme Court Says They’re Owed By The State The Ohio Supreme Court ordered the state to pay nursing homes up to $1 billion. Four months later, the money still hasn’t arrived. (Staver, 1/25) https://www.cleveland.com/news/2026/01/ohio-nursing-homes-still-waiting-on-1-billion-supreme-court-says-theyre-owed.html?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_gpBXeZYcgHIm2YchRrmzFYo8Rf-zXKmHfrJcNY4Jk5pkwY0GjSx85sWxOhTpjA1McPQGjrmseUrjUHvyRhpMfuobJgQ&_hsmi=400350224&utm_content=400350224&utm_source=hs_email PHARMA AND TECH The New York Times: Genetic Data From Over 20,000 U.S. Children Misused For ‘Race Science’ Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease. They also promised that the children’s sensitive data would be closely guarded in the decade-long study, which got underway in 2015. Promotional materials included a cartoon of a Black child saying it felt good knowing that “scientists are taking steps to keep my information safe.” The scientists did not keep it safe. (McIntire, 1/24) https://www.nytimes.com/2026/01/24/us/children-genetics-race-science.html?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9vUjRwdUup7upVVTHBXpviSdF9q-LxPGd5QZsBOXys4r-2PdpEeYu-yAhZWlUaf0mTZqI6-O654PTCzgpCofD_M_VrVQ&_hsmi=400350224&utm_content=400350224&utm_source=hs_email Stat: New FDA Pathway For CRISPR Treatments Raises Concerns When Baby KJ was introduced to the world last year as the first recipient of a personalized gene-editing treatment, the logical next question was: How can we get to more Baby KJs? (Mast, 1/26) https://www.statnews.com/2026/01/26/fda-makary-prasad-crispr-gene-editing-concerns-baby-kj/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_8IdRJEAYVO6jvVGU1LYczbiEBZZeifeVBMsDgtVje5uV8VNKhgFCvt9u4Vt0jbkqfmqs3WViYvJQyENdWy6Tw3p1VpA&_hsmi=400350224&utm_content=400350224&utm_source=hs_email CIDRAP: Narrow-Spectrum C Difficile Antibiotic Shows Promise In Phase 2 Study A narrow-spectrum antibiotic candidate for Clostridioides difficile infection (CDI) was highly effective and well-tolerated in a small phase 2 trial, researchers reported yesterday in The Lancet Infectious Diseases. (Dall, 1/23) https://www.cidrap.umn.edu/clostridium-difficile/narrow-spectrum-c-difficile-antibiotic-shows-promise-phase-2-study?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--eVDBB9pbDnG4465mjP6C_7DUGQdnJD6BrU-B43b8dus9apvK_sPFHfvxdjbNScNPb0nlmZbEulLk6W5rXowLil_x_1w&_hsmi=400350224&utm_content=400350224&utm_source=hs_email